GlaxoSmithKline (GSK) Assets US GAAP (year values) |
|||||||||
2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
Assets, £ | 79 103 000 000 | 60 146 000 000 | 60 146 000 000 | 59 005 000 000 | 59 005 000 000 | 58 511 000 000 | |||
Changes by years, y/y, % | 0% | -24% | 0% | -2% | 0% | +0.3% |
GlaxoSmithKline. Assets, £
GlaxoSmithKline. Assets, changes, %
GlaxoSmithKline (GSK) Assets US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
Assets, £ | 59 461 000 000 | 60 862 000 000 | 59 005 000 000 | 59 005 000 000 | 58 511 000 000 | 58 511 000 000 | ||
Changes by years, y/y, % | -33% | +1% | -2% | -2% | 0% | |||
Changes by quarters, q/q, % | 0% | +2% | -3% | 0% | -1% |